27,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
14 °P sammeln
  • Broschiertes Buch

"A Study on Inn-Virto Anti-Diabetic Activity of Bestasitostteerol" is a comprehensive research book written by G. Paneer Selvam, a renowned researcher in the field of pharmaceutical sciences. The book offers a detailed analysis of the therapeutic potential of Bestasitostteerol, a bioactive compound found in natural sources, in managing diabetes mellitus. The author presents a critical review of the existing literature on the pathophysiology of diabetes, the limitations of current treatment options, and the need for alternative approaches. He then proceeds to describe the methodology and…mehr

Produktbeschreibung
"A Study on Inn-Virto Anti-Diabetic Activity of Bestasitostteerol" is a comprehensive research book written by G. Paneer Selvam, a renowned researcher in the field of pharmaceutical sciences. The book offers a detailed analysis of the therapeutic potential of Bestasitostteerol, a bioactive compound found in natural sources, in managing diabetes mellitus. The author presents a critical review of the existing literature on the pathophysiology of diabetes, the limitations of current treatment options, and the need for alternative approaches. He then proceeds to describe the methodology and results of his experiments, which involved testing the efficacy of Bestasitostteerol in vitro. The book provides a thorough discussion of the molecular mechanisms underlying the anti-diabetic effects of Bestasitostteerol, including its ability to enhance insulin sensitivity, suppress gluconeogenesis, and modulate glucose uptake in cells. The author also explores the potential side effects and safety considerations of using Bestasitostteerol as a therapeutic agent. Overall, "A Study on Inn-Virto Anti-Diabetic Activity of Bestasitostteerol" is a valuable resource for researchers, academics, and healthcare professionals interested in developing novel anti-diabetic drugs from natural sources. It provides a detailed understanding of the potential of Bestasitostteerol as a safe and effective alternative to conventional treatments for diabetes.